3VC-19867-98287
1 vaccination
3 coded responses
11 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 299 / SC
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Pfizer-BioNTech
- 2021-01-07
- 2021-01-08
- 2021-01-09
-
2021-01-10
Survey response — days 1–6 daily, dose 1MedDRA: Injection site pruritus — Feeling: Good · Site: ItchingFree text: Injection site was itching for a few minutes after me pressing on it, subsided shortly after though. Very mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-11
-
2021-01-12
Survey response — days 1–6 daily, dose 1MedDRA: Oropharyngeal pain — Feeling: FairFree text: Mild sore throat, possibly drainage in the back of my throatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
- 2021-01-14
- 2021-01-21
- 2021-04-08
-
2022-01-07
Survey response — 12 months, dose 1MedDRA: COVID-19, Enterovirus infection, Rhinovirus infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Positive for rhino enterovirus. Worse symptoms than when I had Covid-19MedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Report sent to call center — 12 months, dose 1Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
-
2022-01-10
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-01-07 | Successful 2022-01-10 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Injection site was itching for a few minutes after me pressing on it, subsided shortly after though. Very mild
Systemic reaction (other): Mild sore throat, possibly drainage in the back of my throat
Release 10 — 12 months, dose 1
Symptoms: Positive for rhino enterovirus. Worse symptoms than when I had Covid-19
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Enterovirus infection | · | · | ✓ |
| SD | Rhinovirus infection | · | · | ✓ |
| SRO | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Oropharyngeal pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release